UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HDL cholesterol and protective factors in atherosclerosis

Circulation (New York, N.Y.), 2004-06, Vol.109 (23 Suppl 1), p.III8-II14

2004

Volltextzugriff (PDF)

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

The New England journal of medicine, 2009-04, Vol.360 (18), p.1851-1861

2009

Volltextzugriff (PDF)

Inflammation in atherosclerosis and implications for therapy

Circulation (New York, N.Y.), 2004-06, Vol.109 (23 Suppl 1), p.III20-III26

2004

Volltextzugriff (PDF)

Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets

The American journal of cardiology, 2012-07, Vol.110 (1), p.3A-14A

2012

Volltextzugriff (PDF)

Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events: A Meta-Analysis of Statin Trials

Journal of the American College of Cardiology, 2014-08, Vol.64 (5), p.485-494

2014

Volltextzugriff (PDF)

Pharmacotherapies for lipid modification: beyond the statins

Nature reviews cardiology, 2013-10, Vol.10 (10), p.560-570

2013

Volltextzugriff (PDF)

Statin Intolerance: the Clinician’s Perspective

Current atherosclerosis reports, 2015-12, Vol.17 (12), p.69-69, Article 69

2015

Volltextzugriff (PDF)

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

The New England journal of medicine, 2001-06, Vol.344 (26), p.1959-1965

2001

Volltextzugriff (PDF)

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

JAMA : the journal of the American Medical Association, 2012-03, Vol.307 (12), p.1302

2012

Volltextzugriff (PDF)

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

The American journal of cardiology, 2014, Vol.113 (1), p.76-83

2014

Volltextzugriff (PDF)

Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.717-724

2004

Volltextzugriff (PDF)

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

The Lancet (British edition), 2010-07, Vol.376 (9738), p.333-339

2010

Volltextzugriff (PDF)

Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis

Circulation (New York, N.Y.), 2013-10, Vol.128 (14), p.1504-1512

2013

Volltextzugriff (PDF)

Cholesterol: Can't Live With It, Can't Live Without It

Methodist DeBakey cardiovascular journal, 2019-01, Vol.15 (1), p.9-15

2019

Volltextzugriff (PDF)

Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy

The American journal of cardiology, 2010-05, Vol.105 (9), p.1289-1296

2010

Volltextzugriff (PDF)

Role of C-Reactive Protein in Coronary Risk Reduction: Focus on Primary Prevention

The American journal of cardiology, 2007-03, Vol.99 (5), p.718-725

Gotto, Antonio M., MD, DPhil

2007

Volltextzugriff (PDF)

High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease

The American heart journal, 2002-12, Vol.144 (6), p.S33-S42

Gotto, Antonio M.

2002

Volltextzugriff (PDF)

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Circulation (New York, N.Y.), 2000-02, Vol.101 (5), p.477-484

2000

Volltextzugriff (PDF)

Effects of Increasing High-Density Lipoprotein Cholesterol and Decreasing Low-Density Lipoprotein Cholesterol on the Incidence of First Acute Coronary Events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study)

The American journal of cardiology, 2009-09, Vol.104 (6), p.829-834

2009

Volltextzugriff (PDF)

Statin therapy and the elderly: SAGE advice?

Circulation (New York, N.Y.), 2007-02, Vol.115 (6), p.681-683

Gotto, Jr, Antonio M

2007

Volltextzugriff (PDF)

Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis

BMC medical genetics, 2009-10, Vol.10 (1), p.111-111, Article 111

2009

Volltextzugriff (PDF)

Prevalence of the Apolipoprotein E Arg145Cys Dyslipidemia At-Risk Polymorphism in African-Derived Populations

The American journal of cardiology, 2014-01, Vol.113 (2), p.302-308

2014

Volltextzugriff (PDF)

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events

Annals of internal medicine, 2005-01, Vol.142 (2), p.95

2005

Volltextzugriff (PDF)

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

The New England journal of medicine, 2010-12, Vol.363 (25), p.2406-2415

2010

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(99)

Sprache

Englisch
(99)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

HDL cholesterol and protective factors in atherosclerosis

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

Inflammation in atherosclerosis and implications for therapy

Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets

Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events: A Meta-Analysis of Statin Trials

Pharmacotherapies for lipid modification: beyond the statins

Statin Intolerance: the Clinician’s Perspective

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis

Cholesterol: Can't Live With It, Can't Live Without It

Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy

Role of C-Reactive Protein in Coronary Risk Reduction: Focus on Primary Prevention

High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease

Residual macrovascular risk in 2013: what have we learned?

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Effects of Increasing High-Density Lipoprotein Cholesterol and Decreasing Low-Density Lipoprotein Cholesterol on the Incidence of First Acute Coronary Events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study)

Statin therapy and the elderly: SAGE advice?

Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis

Prevalence of the Apolipoprotein E Arg145Cys Dyslipidemia At-Risk Polymorphism in African-Derived Populations

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

Aktive Filter

Suchergebnisse filtern